FDA clears Varians motion-tracking system
Varian Medical Systems has received FDA 510(k) clearance for its motion tracking transponder.
The Surface Beacon Transponder is designed for use with the Varian Calypso system as a real-time tracking device capable of monitoring motion during radiotherapy treatments for indications anywhere in the body. It is placed temporarily on the skin to track respiratory and other patient motion during radiotherapy.
Varian acquired Calypso in October 2011 to extend its range of real-time tracking tools.
The Surface Beacon Transponder is designed for use with the Varian Calypso system as a real-time tracking device capable of monitoring motion during radiotherapy treatments for indications anywhere in the body. It is placed temporarily on the skin to track respiratory and other patient motion during radiotherapy.
Varian acquired Calypso in October 2011 to extend its range of real-time tracking tools.